twelve patients completed a double-blind , crossover antiarrhythmic drug trial in which 300 mg of quinidine , 500 mg of procainamide , 100 mg of phenytoin , or placebo was given four times daily on subsequent weeks .
C0003195
antiarrhythmic drug
C0033216
procainamide